ASX Share rice
Sun 09 May 2021 - 05:38:pm (Sydney)

VTI Share Price

VISIONEERING TECHNOLOGIES, INC.VTIHealth Care Equipment & Services

VTI Company Information

Name:

Visioneering Technologies, Inc

Sector:

Healthcare

Industry:

Medical Devices

Address:

10745 Westside Way Alpharetta GA United States 30009

Phone:

844 884 5367

CEO & Exec. Director:

Dr. Stephen Snowdy

Chief Financial Officer:

Mr. Brian D. Lane CPA

Sr. VP of Sales & Marketing:

Mr. Tony Sommer Jr.

Founder & Medical Adviser:

Dr. Richard A. Griffin

Company Sec.:

Ms. Leanne Ralph BBus, ACIS, AAICD

Exec. Director of Marketing:

Ms. Layna L. Mendlinger

Exec. Director of Professional Affairs:

Dr. Douglas P. Benoit OD, FAAO

Company Overview:

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. It offers NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

VTI Share Price Information

Shares Issued:

2.36B

Market Capitalisation:

$33.09M

Revenue (TTM):

$5.11M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.056

Profit Margin:

-1.8098

Operating Margin (TTM):

$-1.51

Return On Assets (TTM):

$-0.89

Return On Equity (TTM):

$-4.93

Quarterly Revenue Growth (YOY):

-0.099

Gross Profit(TTM):

$786K

Diluted Earnings Per Share (TTM):

$-0.016

VTI CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-31,160.74

Change To Liabilities:

$50K

Total Cashflow From Investing Activities:

$-24,000

Net Borrowings:

$1.04M

Net Income:

$-9,239,000

Total Cash From Operating Activities:

$-6,508,000

Depreciation:

$133K

Change To Inventory:

$1.66M

Change To Account Receivables:

$-109,000

Sale Purchase Of Stock:

$5.99M

Capital Expenditures:

$1K

VTI Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-11,991,690.47

Net Income:

$-11,995,585.56

Gross Profit:

$2.89M

Operating Income:

$-10,012,983.64

Interest Expense:

$433.65K

Income Tax Expense:

$3K

Total Revenue:

$6.63M

Cost Of Revenue:

$3.74M

VTI Balance Sheet

Balance Sheet Date:

2020-12-31

Intangible Assets:

$229.81K

Total Liabilities:

$8.69M

Total Stockholder Equity:

$-2,213,710.72

Other Current Liabilities:

$1.77M

Total Assets:

$6.47M

Common Stock:

$0.99M

Retained Earnings:

$-80,823,000

Other Assets:

$179K

Cash:

$3.13M

Total Current Liabilities:

$2.71M

Property - Plant & Equipment:

$206K

Net Tangible Assets:

$-1,882,000

Total Current Assets:

$4.43M

Long-Term Debt:

$3.67M

Net Receivables:

$0.94M

Short-Term Investments:

$729.68K

Inventory:

$550K

Accounts Payable:

$330K

Non Currrent Assets (Other):

$232.41K

Short-Term Investments:

$729.68

Non Current Liabilities (Other):

$1.49M

Non Current Liabilities Total:

$5.16M

VTI Share Price History

VTI News

06 Nov, 2020
ATLANTA, GA / ACCESSWIRE / November 5, 2020 / Visioneering Technologies (ASX:VTI), US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc.
15 Oct, 2020
Shareholders in Visioneering Technologies, Inc. (ASX:VTI) may be thrilled to learn that the covering analyst has just...
14 Oct, 2020
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
04 Aug, 2020
LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / The SNN Network Virtual Conference will take place on August 3rd \\- 6th, 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.